Preparation method of polysubstituted phenyl propargylamine compound
Through transition metal copper catalysis and O-benzoylhydroxylamine capture of carbinic bifunctional grouping, the multi-substituted phenylparaginamine series compounds were constructed, and the complexity and yield of the synthesis of drug molecules containing proparaginamine in the prior art was solved. The problem has achieved efficient and highly compatible products and has broad application prospects.
Patent Information
- Application Number
- CN202310625209.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-30
- Publication Date
- 2024-12-03
AI Technical Summary
In the prior art, when synthesizing drug molecules containing a propargylamine backbone, the methods are complex, the yield is low, the reaction conditions are harsh, the selectivity is weak, and it is difficult to be compatible with a variety of sensitive groups.
The transition metal copper catalyzed to form a propargyl copper intermediate, and the carbine-geogenic bifunctionalization was captured by O-benzoylhydroxylamine to construct a series of polysubstituted phenyl propargylamine compounds. CuI was used as the optimal catalyst to react at 80°C. 6 hours, use argon to protect the environment.
实现了化学选择性高、底物适用性广、操作简便,产物对各种官能团兼容,产率高,能够进一步转化构建新型化合物,具有广泛的生物或药物活性应用前景。
Smart Images

Figure SMS_1 
Figure QLYQS_1
Abstract
Description
Technical Field
[0001] The present invention relates to a derivative of a propargylamine skeleton, and in particular to a preparation method of a series of polysubstituted phenylpropargylamine compounds. Background Art
[0002] Aryl propargylamine is an important natural active organic compound skeleton, and is also an important chemical raw material and organic synthetic drug intermediate. For example, in the field of materials science, the propargylamine skeleton is an important synthetic intermediate for drugs and dyes; in the field of natural active products, many natural active products contain the propargylamine skeleton, and some complex natural products are synthesized from simple propargylamine to target products with natural activity.
[0003] In addition, based on the application of propargylamine skeleton in natural active molecules and the application of such natural products in medicine and materials, a series of drug molecules containing propargylamine skeleton have been artificially synthesized. For example, Propyzamide D3 is a drug molecule containing propargylamine structure, but the method of synthesizing drug molecules containing propargylamine skeleton is relatively complicated and has low yield, so it is imperative to invent an efficient method for synthesizing polysubstituted aryl propargylamine compounds.
[0004] Through our literature review, there are many effective ways to synthesize propargylamine compounds, but most of them have certain defects, such as limited substrate range, harsh reaction conditions, and weak product selectivity. Based on this point, the present invention aims to develop an effective method to synthesize compounds containing this structural feature, which will have excellent convertibility and have a very broad application prospect.
[0005] Based on this point, the present invention aims to develop a strategy of forming a propargyl copper intermediate by transition metal copper catalysis and capturing the propargyl copper intermediate by an electrophilic reagent to apply this strategy to carbene difunctionalization to construct a series of polysubstituted phenyl propargylamine series compounds. The method of the present invention has good compatibility with various groups such as halogen (fluorine, chlorine, bromine, iodine), methyl, ester, heterocyclic and other sensitive groups, and these groups themselves have good reactivity, so the obtained product can be further transformed through other organic chemical reactions, thereby introducing more functional groups on the propargylamine, and at the same time, other compounds of new structures can be constructed. Summary of the invention
[0006] The object of the present invention is to provide a method for preparing a series of polysubstituted phenylpropargylamine compounds, which has high chemical selectivity, wide substrate applicability and simple operation.
[0007] The present invention adopts hydrazone, phenylacetylene and O-Benzoylhydroxylamine is used as a reaction substrate. Under the catalytic action of a transition metal catalyst, the reaction is carried out at a certain temperature for a period of time to obtain a series of polysubstituted phenylpropargylamine compounds. The general reaction formula is as follows:
[0008] Where R is a substituent, R 1 and R 2 For various alkyl and aryl substituents.
[0009] Wherein, the organic solvent is ethylene dichloride, tetrahydrofuran, dimethyl sulfoxide, ethylene glycol dimethyl ether, acetonitrile, NN-dimethylformamide, dichloromethane or toluene, and ethylene dichloride is the best. The copper catalyst is CuCl2, CuI, Cu(OAc)2, CuSO4, CuBr, CuSCN and Cu(OTf)2, and CuI is the best. The base is DBU, NEt3, NaOAc, LiOAc and BnNMe2, and BnNMe2 is the best.
[0010] The reaction temperature was 80°C and the reaction time was 6 hours.
[0011] The reaction was carried out under argon protection as the reaction environment.
[0012] In the method for preparing a series of polysubstituted phenylpropargylamine compounds, the R 1 and R 2 The group has good compatibility with various substituents, whether it is cyclic alkylamine, acyclic dialkylamine and alkylbenzylamine, it can have good yields; O- Benzoylhydroxylamine is used to capture the propargyl copper intermediate to achieve the geminal difunctionalization of carbene, thereby constructing C(sp)-C(sp3) bonds and C(sp3)-N bonds to obtain a series of substituted phenylpropargylamine compounds.
[0013] The beneficial effects of the present invention are: O- When benzoylhydroxylamine is a cyclic or non-cyclic dialkylamine, different propargylamine compounds can be obtained; the reaction has high chemical selectivity, wide substrate applicability, simple operation and high product yield; at 80°C, the reaction time is 6 hours, which is sufficient to reach the gram level; since the product has good compatibility with various functional groups, it is possible to purposefully and effectively synthesize various active intermediate molecules containing aromatic propargylamine compounds, and the obtained products can be further transformed through other organic chemical reactions to construct other novel compounds containing propargylamine structures, which have potential biological or pharmaceutical activities and have very good application prospects in the fields of biomedicine, pesticides and materials science. Implementation
[0014] The following examples are provided to further illustrate the present invention, but are not intended to limit the scope of the present invention. Embodiment 1
[0015] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O -Benzoylhydroxylamine (62.7 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4a with a yield of 83%. The following is the NMR experimental data of product 4a: 1 H NMR (400 MHz, CDCl3): δ 7.54-747 (m, 4H), 7.32 (t, J = 2.8 Hz, 3H), 7.17 (d, J = 8.0 Hz, 2H), 4.74 (s, 1H), 3.77- 3.67 (m, 4H), 2.67 – 2.57 (m,4H), 2.36 (s, 3H). 13 C NMR (101 MHz, CDCl3): δ 137.6, 134.9, 131.9, 129.1, 128.6, 128.4,128.3, 123.0, 88.3, 85.5, 67.3, 62.0, 49.9, 21.3. Embodiment 2
[0016] Under argon atmosphere, 4-methyl-N'-(thiophen-2-ylmethylene)benzenesulfonylhydrazide (53.4 mg, 0.20 mmol), O-Benzoylhydroxylamine (62.7 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4b with a yield of 71%. The following is the nuclear magnetic resonance experimental data of product 4b: 1 H NMR (400 MHz, CDCl3): δ 7.55-7.47 (m, 2H), 7.38-7.31 (m, 3H), 7.29 (dd, J1 = 4.8 Hz, J2 = 0.8 Hz, 1H), 7.25-7.22 (m, 1H), 6.97 (dd, J1 = 5.2 Hz,J2 = 3.6 Hz, 1H), 4.99 (s, 1H), 3.82-3.69 (m, 4H), 2.77-2.61 (m, 4H). 13 C NMR (101 MHz, CDCl3): δ 142.9, 132.0 128.6, 128.5, 126.5, 126.4,125.9, 122.8, 87.7, 84.4, 67.2, 57.9, 49.8. Embodiment 3
[0017] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (62.7 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), 4-propylphenylacetylene (57.4 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4c with a yield of 73%. The following is the NMR experimental data of product 4c: 1 H NMR (400 MHz, CDCl3): δ 7.50 (d, J = 8.0 Hz, 2H), 7.42 (d, J = 8.0Hz, 2H), 7.16 (d, J = 8.0 Hz, 2H), 7.13 (d, J = 8.0 Hz, 2H), 4.73 (s, 1H), 3.77-3.65 (m, 4H), 2.66-2.54 (m, 6H), 2.35 (s, 3H), 1.69-1.57 (m, 2H), 0.93(t, J = 7.3 Hz, 3H). 13 C NMR (101 MHz, CDCl3): δ 143.2, 137.5, 135.0, 131.8, 129.0, 128.65,128.57, 120.3, 88.5, 84.7, 67.3, 61.9, 49.9, 38.0, 24.5, 21.2, 13.9. Embodiment 4
[0018] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (62.7 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), 4-fluorophenylacetylene (48.0 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4d with a yield of 66%. The following is the nuclear magnetic resonance experimental data of product 4d: 1 H NMR (400 MHz, CDCl3): δ 7.51-7.45 (m, 4H), 7.17 (d, J = 8.0 Hz,2H), 7.05-6.98 (m, 2H), 4.72 (s, 1H), 3.77-3.67 (m, 4H), 2.66-2.56 (m, 4H),2.35 (s, 3H). 13 C NMR (101 MHz, CDCl3): δ 162.6 (d, J = 250.3 Hz), 137.7, 134.8,133.8 (d, J = 8.4 Hz), 129.1, 128.6, 119.2 (d, J = 3.5 Hz), 115.7 (d, J =22.1 Hz), 87.24, 85.19, 67.27, 61.88, 50.01, 21.24. Embodiment 5
[0019] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (62.7 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), 3-thiopheneacetylene (43.2 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4e with a yield of 73%. The following is the NMR experimental data of the product 4e: 1 H NMR (400 MHz, CDCl3): δ 7.52-7.45 (m, 3H), 7.27 (dd, J1 = 4.8 Hz, J2= 3.2 Hz, 1H), 7.20-7.13 (m, 3H), 4.71 (s, 1H), 3.77-3.66 (m, 4H), 2.66-2.55(m, 4H), 2.35(s, 3H). 13 C NMR (101 MHz, CDCl3): δ 137.6, 134.8, 130.1, 129.0, 128.7, 128.6,125.4, 122.1, 85.0, 83.3, 67.3, 62.0, 50.0, 21.2. Embodiment 6
[0020] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (66.9 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4f with a yield of 71%. The following is the NMR experimental data of the product 4f: 1 H NMR (400 MHz, CDCl3): δ 7.54-7.47 (m, 4H), 7.36-7.30 (m, 3H), 7.17(d, J = 8.0 Hz, 2H), 4.77 (s, 1H), 2.92-2.84 (m, 4H), 2.76-2.62 (m, 4H), 2.35(s, 3H). 13 C NMR (101 MHz, CDCl3): δ 137.5, 135.0, 131.9, 129.0, 128.5, 128.4,128.3, 123.2, 88.4, 85.3, 62.6, 51.8, 28.5, 21.2. Embodiment 7
[0021] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (83.1 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4g with a yield of 75%. The following is the nuclear magnetic resonance experimental data of product 4g: 1 H NMR (400 MHz, CDCl43): δ 7.54-7.46 (m, 4H), 7.35-7.29 (m, 3H), 7.16(d, J = 7.6 Hz, 2H), 4.79 (s, 1H), 4.11 (q, J = 7.2 Hz, 2H), 2.97 (d, J =15.2 Hz, 1H), 2.69 (d, J = 11.6 Hz, 1H), 2.54 (td, J1 = 11.2 Hz, J2 = 2.8 Hz,1H), 2.35 (s, 3H), 2.31-2.18 (m, 2H), 2.00-1.80 (m, 3H), 1.72-1.60 (m, 1H),1.23 (t, J = 7.2 Hz, 3H). 13 C NMR (101 MHz, CDCl3): δ 175.4, 137.3, 135.4, 131.9, 128.9, 128.40,128.39, 128.2, 123.3, 88.0, 85.8, 61.7, 60.3, 51.7, 46.8, 41.4, 28.8, 28.4,21.2, 14.3. Embodiment 8
[0022] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (85.2 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4h with a yield of 74%. The following is the nuclear magnetic resonance experimental data of the product 4h: 1 H NMR (400 MHz, CDCl3): δ 8.28 (d, J = 4.4 Hz, 2H), 7.55 (d, J = 8.0Hz, 2H), 7.51-7.44 (m, 2H), 7.33-7.26 (m, 3H), 7.19 (d, J = 8.0 Hz, 2H), 6.44(t, J = 4.8 Hz, 1H), 4.86 (s, 1H), 3.90-3.79 (m, 4H), 2.74-2.65 (m, 4H), 2.36(s, 3H). 13 C NMR (101 MHz, CDCl3): δ 161.7, 157.8, 137.5, 135.0, 131.9, 129.0,128.6, 128.35, 128.26, 123.1, 109.8, 88.3, 85.4, 61.6, 49.4, 43.8, 21.3. Embodiment 9
[0023] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (78.9 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4i with a yield of 60%. The following is the NMR experimental data of product 4i: 1 H NMR (400 MHz, CDCl3): δ 7.55-7.47 (m, 4H), 7.34-7.28 (m, 3H), 7.17(d, J = 7.6 Hz, 2H), 4.80 (s, 1H), 3.93 (s, 4H), 2.76-2.60 (m, 4H), 2.35 (s,3H), 1.85-1.68 (m, 4H). 13 C NMR (101 MHz, CDCl3): δ 137.4, 135.7, 132.0, 129.0, 128.4, 128.3,128.2, 123.4, 107.4, 87.8, 86.1, 64.3, 61.3, 47.7, 35.2, 21.3. Embodiment 10
[0024] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (57.9 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4j with a yield of 54%. The following is the nuclear magnetic resonance experimental data of product 4j: 1 H NMR (400 MHz, CDCl3): δ 7.55 (d, J = 8.0 Hz, 2H), 7.52-7.48 (m,2H), 7.35-7.29 (m, 3H), 7.16 (d, J = 8.0 Hz, 2H), 5.01 (s, 1H), 2.68-2.49 (m,4H), 2.35 (s, 3H), 1.07 (t, J = 7.2 Hz, 6H). 13 C NMR (101 MHz, CDCl3): δ 137.0, 131.9, 128.9, 128.4, 128.1, 123.6,87.4, 86.5, 56.8, 44.6, 21.2, 13.7. Embodiment 11
[0025] Under argon atmosphere, 4-methyl-N'-(4-methylbenzylidene)benzenesulfonyl hydrazide (57.6 mg, 0.20 mmol), O-Benzoylhydroxylamine (72.3 mg, 0.3 mmol, 1.5 equiv.) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4k with a yield of 58%. The following is the NMR experimental data of the product 4k: 1 H NMR (400 MHz, CDCl3): δ 7.60-7.53 (m, 4H), 7.41 (d, J = 7.2 Hz, 2H), 7.37-7.30 (m, 5H), 7.27-7.22 (m, 1H), 7.17 (d, J = 8.0 Hz, 2H), 4.89 (s,1H), 3.71 (d, J =12.8, 1H), 3.62 (d, J =13.2, 1H), 2.35 (s, 3H), 2.24 (s,3H). 13 C NMR (101 MHz, CDCl3): δ 139.5, 137.3, 136.2, 132.0, 129.1, 129.0,128.5, 128.42, 128.39, 128.3, 127.2, 123.5, 88.6, 85.1, 59.5, 58.9, 38.1,21.3. Embodiment 12
[0026] Under argon atmosphere, the complex (4-methylbenzylidene)benzenesulfonyl hydrazide (90.2 mg, 0.20 mmol), O-Benzoylhydroxylamine (62.7 mg, 0.3 mmol, 1.5 equiv..) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4l with a yield of 59%. The following is the nuclear magnetic resonance experimental data of the product 4l: 1 H NMR (400 MHz, CDCl3): δ 7.54-7.47 (m, 2H), 7.39 (d, J = 8.0 Hz,1H), 7.35-7.25 (m, 5H), 4.71 (s, 0.49H), 4.70 (s, 0.50H), 3.80-3.68 (m, 4H),3.00-2.88 (m, 2H), 2.71-2.58 (m, 4H), 2.55-2.39 (m, 2H), 2.31 (t, J = 10.4Hz, 1H), 2.20-1.92 (m, 4H), 1.69-1.41 (m, 6H), 0.91 (s, 3H). 13 C NMR (101 MHz, CDCl3): δ 221.0, 139.4, 136.5, 135.3, 131.9, 129.26-129.24 (m), 128., 128.3, 126.2, 125.3, 123.2, 88.24, 85.52-85.50 (m), 67.3,61.9, 50.6, 50.0, 48.1, 44.5, 38.2, 36.0, 31.7, 29.6, 26.6, 25.8, 21.7, 14.0. Embodiment 13
[0027] Under argon atmosphere, the complex (4-methylbenzylidene)benzenesulfonyl hydrazide (106.8 mg, 0.20 mmol), O-Benzoylhydroxylamine (62.7 mg, 0.3 mmol, 1.5 equiv..) and CuI (3.8 mg, 0.02 mmol, 10 mol%) were added to a 25 mL pressure tube dried in an oven. The reaction tube was evacuated and replaced with argon three times. Under argon conditions, DCE (2.0 mL), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.) and BnNMe2 (81.0 mg, 0.60mmol, 3.0 equiv.) were added to the reaction tube in sequence. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through diatomaceous earth, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4m with a yield of 42%. The following is the NMR experimental data of the product 4m: 1 H NMR (400 MHz, CDCl3): δ 7.79 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.4Hz, 2H), 7.56-7.50 (m, 2H), 7.38-7.31 (m, 3H), 6.96 (d, J = 2.4 Hz, 1H), 6.92(d, J = 9.2 Hz, 1H), 6.66 (dd, J1 = 9.2 Hz, J2 = 2.8 Hz, 1H), 4.90 (s, 1H), 3.84 (s, 3H), 3.81-3.72 (m, 4H), 3.70 (s, 3H), 3.68 (s, 2H), 2.73-2.58 (m, 4H), 2.37 (s, 3H). 13 C NMR (101 MHz, CDCl3): δ 171.5, 169.3, 156.1, 143.2, 136.1, 135.2,132.0, 131.1, 130.7, 129.8, 129.0, 128.7, 128.5, 122.7, 115.2, 112.4, 111.7,101.3, 89.5, 84.0, 67.2, 61.8, 55.8, 52.3, 49.9, 30.3, 13.5 Embodiment 14 4n
[0028] 4-Methyl(4-methylbenzylidene)benzenesulfonylhydrazide (57.6 mg, 0.20 mmol), phenylacetylene (40.8 mg, 0.40 mmol, 2 equiv.),O -Benzoylhydroxylamine (118.8 mg, 0.3 mmol, 1.5 equiv.), CuI (3.8 mg, 0.02 mmol, 10 mol%), BnNMe2 (81.0 mg, 0.60 mmol, 3.0 equiv.) and DCE (2.0 mL) were added to an oven-dried 25 mL pressure tube, which was filled with Ar and immediately sealed. The reaction system was stirred at 80 °C for 6 h, and the reaction process was monitored by TLC. After the reaction was completed, the mixture was cooled to room temperature, filtered through celite, and washed with ethyl acetate. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography to obtain the desired product 4n with a yield of 60%. The following is the NMR experimental data of the product 4n: 1 H NMR (400 MHz, CDCl3): δ 8.37 (dd, J1= 12.0 Hz, J2= 4.8 Hz, 1H), 7.52-7.45 (m, 4H), 7.39 (t, J = 6.4 Hz, 1H), 7.34-7.28 (m, 3H), 7.16-7.02 (m,6H), 4.79 (s, 1H), 3.45-3.30 (m, 2H), 2.89-2.67 (m, 4H), 2.57-2.29 (m, 9H). 13 C NMR (101 MHz, CDCl3): δ 157.81-157.79 (m), 146.70-146.68 (m), 139.60-139.56 (m), 139.3, 137.94-137.93 (m), 137.3, 137.28-137.25 (m), 135.4,133.50-133.47 (m), 132.7, 132.66-132.64 (m), 131.9, 131.0, 129.04-129.02 (m),128.9, 128.44-128.43 (m), 128.4, 128.2, 126.07-126.03 (m), 123.3, 122.12-122.11 (m), 87.8, 86.07-86.05 (m), 61.52-61.50 (m), 52.88-52.81 (m), 49.48-49.39 (m), 31.9, 31.5, 31.45-31.23 (m), 31.21-30.95 (m), 21.2.
Claims
1. A method for preparing a series of polysubstituted phenylpropargylamine compounds, comprising the following steps: In an organic solvent, a hydrazone of formula I, a terminal alkyne of formula II and a O -benzoylhydroxylamine is used as a reaction substrate, and under the catalytic action of a transition metal catalyst, a certain temperature condition and the protection of an inert gas, the reaction is carried out for a period of time to obtain a multi-substituted phenylpropargylamine series compound having a structure such as Formula IV; 2. The hydrazone of formula I according to claim 1, characterized in that: The substituted R 3 Groups include, but are not limited to, methyl, methoxy, halogen, ester, amide, fused aromatic rings, and heteroaromatic rings.
3. The terminal alkyne of substrate according to structure II according to claim 1, characterized in that: The R 4 The groups include, but are not limited to, terminal alkynes of heteroaromatic rings and various electron withdrawing and donating groups attached to the para, meta and ortho positions of the phenyl group.
4. The substrate of structure III according to claim 1 O -Benzoylhydroxylamine, characterized in that: The R 1 Group and R 2 These include, but are not limited to, cyclic alkylamines, acyclic dialkylamines, and alkylbenzylamines.
5. The method for preparing a series of polysubstituted phenylpropargylamine compounds according to claim 1, characterized in that: The organic solvent includes, but is not limited to, ethylene dichloride, tetrahydrofuran, dimethyl sulfoxide, ethylene glycol dimethyl ether, acetonitrile, NN-dimethylformamide, dichloromethane and toluene.
6. The method for preparing a series of polysubstituted phenylpropargylamine compounds according to claim 1, characterized in that: The temperature is 40°C-100°C, the time is 4h-12h, and the protective gas includes but is not limited to N2 and Ar.
7. The method for preparing a series of polysubstituted phenylpropargylamine compounds according to claim 1, characterized in that: The copper catalyst includes but is not limited to CuCl2, CuI, Cu(OAc)2, CuSO4, CuBr, CuSCN and Cu(OTf)2.
8. The method for preparing a series of polysubstituted phenylpropargylamine compounds according to claim 1, characterized in that: The base includes but is not limited to DBU, NEt3, NaOAc, LiOAc and BnNMe2.
